Antihypertensive Medications and Blood Sugar: Theories and Implications

Overview

Journal Can J Cardiol

Publisher Elsevier

Specialty Cardiology & Vascular Diseases

Date 2006 Mar 8

PMID 16520854

Citations 20

Authors

David F Blackburn

Thomas W Wilson

Affiliations

Soon will be listed here.

Abstract

Increased rates of diabetes have been reported with thiazide diuretics and beta-blockers, but not with angiotensin-converting enzyme inhibitors, angiotensin receptor blockers or calcium channel blockers. These observations are important because significant glycemic effects of drugs may be a source of accelerated cardiovascular risk that is not detectable during restricted clinical trial follow-up periods. The extent to which diabetes is affected by these medications remains unclear, as is the precise mechanism by which diabetes is promoted. However, several plausible theories are presented herein. Although drug-induced diabetes has been a concern for several years, not enough information is available to influence prescribing for the majority of patients. The number one priority should be controlling blood pressure in a timely manner.

Citing Articles

Diabetes in residential aged care: Pharmacological management and concordance with clinical guidelines.

Bhalla H, Huang G, Seaman K, Silva S, Wu B, Wabe N Australas J Ageing. 2024; 43(4):792-801.

PMID: 38961713 PMC: 11671704. DOI: 10.1111/ajag.13351.

Glucose Alterations, Insulin Resistance, Arterial Hypertension, and Renin are Strictly Associated in Pediatric Obesity.

Antoniotti V, Amore M, Caputo M, Fania C, Mancioppi V, Casoli G J Endocr Soc. 2023; 7(8):bvad088.

PMID: 37424701 PMC: 10326241. DOI: 10.1210/jendso/bvad088.

Association of antihypertensive drugs with fracture and bone mineral density: A comprehensive drug-target Mendelian randomization study.

Huang X, Zhang T, Guo P, Gong W, Zhu H, Zhao M Front Endocrinol (Lausanne). 2023; 14:1164387.

PMID: 37056679 PMC: 10086430. DOI: 10.3389/fendo.2023.1164387.

Using genetics to assess the association of commonly used antihypertensive drugs with diabetes, glycaemic traits and lipids: a trans-ancestry Mendelian randomisation study.

Zhao J, Liu F, Schooling C, Li J, Gu D, Lu X Diabetologia. 2022; 65(4):695-704.

PMID: 35080656 DOI: 10.1007/s00125-021-05645-7.

Metabolic syndrome and its associated factors in Ethiopia: A systematic review and meta-analysis.

Jemere T, Kefale B J Diabetes Metab Disord. 2021; 20(1):1021-1031.

PMID: 34222097 PMC: 8212201. DOI: 10.1007/s40200-021-00815-1.

References

Chan J, Cockram C, Critchley J . Drug-induced disorders of glucose metabolism. Mechanisms and management. Drug Saf. 1996; 15(2):135-57. DOI: 10.2165/00002018-199615020-00005. View

Dahlof B, Sever P, Poulter N, Wedel H, Beevers D, Caulfield M . Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm.... Lancet. 2005; 366(9489):895-906. DOI: 10.1016/S0140-6736(05)67185-1. View

Dominguez L, Barbagallo M, Jacober S, JACOBS D, Sowers J . Bisoprolol and captopril effects on insulin receptor tyrosine kinase activity in essential hypertension. Am J Hypertens. 1998; 10(12 Pt 1):1349-55. DOI: 10.1016/s0895-7061(97)00320-8. View

Hunter S, Harper R, Ennis C, Crothers E, Sheridan B, Johnston G . Effects of combination therapy with an angiotensin converting enzyme inhibitor and thiazide diuretic on insulin action in essential hypertension. J Hypertens. 1998; 16(1):103-9. DOI: 10.1097/00004872-199816010-00015. View

Savage P, Pressel S, Curb J, Schron E, Applegate W, Black H . Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: The Systolic Hypertension in the Elderly Program. SHEP.... Arch Intern Med. 1998; 158(7):741-51. DOI: 10.1001/archinte.158.7.741. View

Miyazaki Y, Murakami H, Hirata A, Fukuoka M, Masuda A, Ura N . Effects of the angiotensin converting enzyme inhibitor temocapril on insulin sensitivity and its effects on renal sodium handling and the pressor system in essential hypertensive patients. Am J Hypertens. 1998; 11(8 Pt 1):962-70. DOI: 10.1016/s0895-7061(98)00085-5. View

Fogari R, Zoppi A, Lazzari P, Preti P, Mugellini A, Corradi L . ACE inhibition but not angiotensin II antagonism reduces plasma fibrinogen and insulin resistance in overweight hypertensive patients. J Cardiovasc Pharmacol. 1998; 32(4):616-20. DOI: 10.1097/00005344-199810000-00014. View

Fogari R, Zoppi A, Corradi L, Lazzari P, Mugellini A, Lusardi P . Comparative effects of lisinopril and losartan on insulin sensitivity in the treatment of non diabetic hypertensive patients. Br J Clin Pharmacol. 1998; 46(5):467-71. PMC: 1873694. DOI: 10.1046/j.1365-2125.1998.00811.x. View

Hansson L, Lindholm L, Niskanen L, Lanke J, Hedner T, Niklason A . Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial. Lancet. 1999; 353(9153):611-6. DOI: 10.1016/s0140-6736(98)05012-0. View

10.

Bakris G, Fonseca V, Katholi R, McGill J, Messerli F, Phillips R . Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial. JAMA. 2004; 292(18):2227-36. DOI: 10.1001/jama.292.18.2227. View

11.

Kostis J, Wilson A, Freudenberger R, Cosgrove N, Pressel S, Davis B . Long-term effect of diuretic-based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetes. Am J Cardiol. 2004; 95(1):29-35. DOI: 10.1016/j.amjcard.2004.08.059. View

12.

Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G . Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med. 2000; 342(3):145-53. DOI: 10.1056/NEJM200001203420301. View

13.

Reneland R, Alvarez E, Andersson P, Haenni A, Byberg L, Lithell H . Induction of insulin resistance by beta-blockade but not ACE-inhibition: long-term treatment with atenolol or trandolapril. J Hum Hypertens. 2000; 14(3):175-80. DOI: 10.1038/sj.jhh.1000964. View

14.

Gress T, Nieto F, Shahar E, Wofford M, Brancati F . Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study. N Engl J Med. 2000; 342(13):905-12. DOI: 10.1056/NEJM200003303421301. View

15.

Fodor J, Frohlich J, Genest Jr J, McPherson P . Recommendations for the management and treatment of dyslipidemia. Report of the Working Group on Hypercholesterolemia and Other Dyslipidemias. CMAJ. 2000; 162(10):1441-7. PMC: 1232457. View

16.

Brown M, Palmer C, CASTAIGNE A, de Leeuw P, Mancia G, Rosenthal T . Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT). Lancet. 2000; 356(9227):366-72. DOI: 10.1016/S0140-6736(00)02527-7. View

17.

. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001; 285(19):2486-97. DOI: 10.1001/jama.285.19.2486. View

18.

. The American Association of Clinical Endocrinologists Medical Guidelines for the Management of Diabetes Mellitus: the AACE system of intensive diabetes self-management--2000 update. Endocr Pract. 2001; 6(1):43-84. View

19.

Malmqvist K, Kahan T, Isaksson H, Ostergren J . Regression of left ventricular mass with captopril and metoprolol, and the effects on glucose and lipid metabolism. Blood Press. 2001; 10(2):101-10. DOI: 10.1080/08037050152112087. View

20.

Fogari R, Zoppi A, Preti P, Fogari E, Malamani G, Mugellini A . Differential effects of ACE-inhibition and angiotensin II antagonism on fibrinolysis and insulin sensitivity in hypertensive postmenopausal women. Am J Hypertens. 2001; 14(9 Pt 1):921-6. DOI: 10.1016/s0895-7061(01)02140-9. View